Other News

The Board of Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, notes the recent rise in the Company's share price and trading volumes and advises the market that it knows of no specific reason for such significant movements. Further to its announcements of 27 May 2020 and 30 June 2020, the Company remains...

Read More

Physiomics have now added both posters presented by Dr Fernando Ortega and Dr Claire Villette at the AACR conference, Atlanta to their website. To view 'A Precision Dosing Application For Advanced Prostate Cancer Chemotherapy' please click here and for 'Modelling the effect of Radiotherapy on tumour growth inhibition: the head and neck tumour case' please click here....

Read More

Physiomics plc (AIM: PYC), is pleased to announce that one of its long-term consultants and collaborators, Dr Hitesh Mistry, has been appointed to the editorial board of the International Journal of Radiation Oncology-Biology-Physics (RedJournal). Click here to read in full....

Read More

Physiomics plc is pleased to announce that it will be attending the 30th EORTC-NCI-AACR SYMPOSIUM in Dublin 13-16 November 2018. The European Organisation for Research and Treatment of Cancer (“EORTC”) acts as a hub for a network of over 930 institutions in 30 countries focused on translational and clinical cancer research. The Symposium is co-hosted by EORTC, the National Cancer Institute (NCI) and the American Association for...

Read More

Physiomics consultant and senior advisor, Dr David Orrell, will give one of the keynote speeches at the 38th International Symposium on Forecasting, Colorado USA on 17th June.   The conference is the premiere international event focused on forecasting across a spectrum of social and scientific disciplines. The event is organised by the International Institute of Forecasters (IIF), which promotes best practices and advancing the field of forecasting through...

Read More
})(jQuery)